Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| COOPER COMPANIES, INC.COO · Entity 3395 | Director | April 01, 2026 | April 06, 2026 |
| Telix Pharmaceuticals LtdTLX · Entity 4101 | Director | May 11, 2026 | May 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
COOPER COMPANIES, INC.
Report date April 01, 2026 · Filed April 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,322 |
Reported balance
After 2026-04-01 transaction · row 1
1 source rowRow 1 · 2026-04-01 · Exercise / conversion · Acquired 3,322 · Balance 3,322 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2026-04-01 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-04-01 · Exercise / conversion · Disposed 3,322 · Balance 0 F2: This award has no expiration date. Units will either vest or be forfeited. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 3,779 |
Reported balance
After 2026-04-01 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-04-01 · Grant · Acquired 3,779 · Balance 3,779 F2: This award has no expiration date. Units will either vest or be forfeited. |
| Common StockSEC Table I · non-derivative | Indirectsee footnote | 11,141 |
Reported balance
Holding disclosure · report date 2026-04-01 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 11,141 F1: Shares held by The Maria Rivas Trust Dated June 24, 2013, of which the Reporting Person is sole trustee. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares held by The Maria Rivas Trust Dated June 24, 2013, of which the Reporting Person is sole trustee.
F2: This award has no expiration date. Units will either vest or be forfeited.
Telix Pharmaceuticals Ltd
Report date May 11, 2026 · Filed May 18, 2026
This filing explicitly reported no securities owned.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Medidata Solutions, Inc.
Report date October 28, 2019 · Filed October 28, 2019
Section 16 reporting ended · disclosed 2019-10-28. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2019-10-28 transaction · row 1
1 source rowRow 1 · 2019-10-28 · Disposition to issuer · Disposed 7,081 · Balance 0 F1: On October 28, 2019, pursuant to the Agreement and Plan of Merger, dated as of June 11, 2019, by and among Dassault Systemes SE ("DS"), Dassault Systemes Americas Corp., a Delaware corporation ("Parent"), 3DS Acquisition 6 Corp., a Delaware corporation and a wholly-owned subsidiary of Parent ("Merger Sub"), and Medidata Solutions, Inc., a Delaware corporation (the "Issuer"), Merger Sub merged with and into the Issuer, with the Issuer surviving as a wholly-owned subsidiary of Parent and an indirect wholly-owned subsidiary of DS (the "Merger"). F2: Disposed of pursuant to the Merger Agreement and by virtue of the Merger, in which each share of Medidata common stock, par value $0.01 per share ("Issuer Common Stock"), issued and outstanding immediately prior to the completion of the Merger (other than restricted share awards held by continuing employees) was converted into the right to receive $92.25 in cash and without interest (the "Merger Consideration"). |
Filing footnotes · ownership attribution and instrument terms
F1: On October 28, 2019, pursuant to the Agreement and Plan of Merger, dated as of June 11, 2019, by and among Dassault Systemes SE ("DS"), Dassault Systemes Americas Corp., a Delaware corporation ("Parent"), 3DS Acquisition 6 Corp., a Delaware corporation and a wholly-owned subsidiary of Parent ("Merger Sub"), and Medidata Solutions, Inc., a Delaware corporation (the "Issuer"), Merger Sub merged with and into the Issuer, with the Issuer surviving as a wholly-owned subsidiary of Parent and an indirect wholly-owned subsidiary of DS (the "Merger").
F2: Disposed of pursuant to the Merger Agreement and by virtue of the Merger, in which each share of Medidata common stock, par value $0.01 per share ("Issuer Common Stock"), issued and outstanding immediately prior to the completion of the Merger (other than restricted share awards held by continuing employees) was converted into the right to receive $92.25 in cash and without interest (the "Merger Consideration").
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 01, 2026 Filed Apr 6, 2026 21:16 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | GrantRestricted Stock Units · Derivative | 3,779 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001755794-26-000001 · primarydocument.xml · derivative · entry 4 Rivas Maria · CIK 0001755794 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,779 Underlying: Common Stock · 3,779 shares Expires not disclosed F2 · derivative.expiration_date: This award has no expiration date. Units will either vest or be forfeited. Read SEC document |
| April 01, 2026 Filed Apr 6, 2026 21:16 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | Exercise / conversionRestricted Stock Units · Derivative | 3,322 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001755794-26-000001 · primarydocument.xml · derivative · entry 3 Rivas Maria · CIK 0001755794 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,322 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.expiration_date: This award has no expiration date. Units will either vest or be forfeited. Read SEC document |
| April 01, 2026 Filed Apr 6, 2026 21:16 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | Exercise / conversionCommon Stock | 3,322 | $0.00 | $0.00 |
DisclosureSEC source: 0001755794-26-000001 · primarydocument.xml · nonDerivative · entry 1 Rivas Maria · CIK 0001755794 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,322 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 18, 2025 Filed Dec 19, 2025 21:18 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | PurchaseCommon Stock | 1,000 | $82.13 | $82,130.00 |
DisclosureSEC source: 0001755794-25-000003 · primarydocument.xml · nonDerivative · entry 1 Rivas Maria · CIK 0001755794 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · see footnote Disclosed balance after: 11,141 F1 · balance_after: Reflects 2,721 shares transferred from the Reporting Person's direct holdings to The Maria Rivas Trust Dated June 24, 2013, of which the Reporting Person is sole trustee. F2 · ownership.nature: Shares held by The Maria Rivas Trust Dated June 24, 2013, of which the Reporting Person is sole trustee. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 20:08 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | GrantRestricted Stock Units · Derivative | 3,322 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-002974 · primarydocument.xml · derivative · entry 4 Rivas Maria · CIK 0001755794 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,322 Underlying: Common Stock · 3,322 shares Expires not disclosed F2 · derivative.expiration_date: This award has no expiration date. Units will either vest or be forfeited. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 20:08 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | Exercise / conversionRestricted Stock Units · Derivative | 2,721 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-002974 · primarydocument.xml · derivative · entry 3 Rivas Maria · CIK 0001755794 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,721 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.expiration_date: This award has no expiration date. Units will either vest or be forfeited. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 20:08 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | Exercise / conversionCommon Stock | 2,721 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-002974 · primarydocument.xml · nonDerivative · entry 1 Rivas Maria · CIK 0001755794 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,721 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 22:03 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | GrantRestricted Stock Units · Derivative | 2,721 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-003267 · primarydocument.xml · derivative · entry 4 Rivas Maria · CIK 0001755794 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,721 Underlying: Common Stock · 2,721 shares Expires not disclosed F2 · derivative.expiration_date: RSU Expiration Date: This award has no expiration date. Units will either vest or be forfeit. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 22:03 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | Exercise / conversionRestricted Stock Units · Derivative | 2,892 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-003267 · primarydocument.xml · derivative · entry 3 Rivas Maria · CIK 0001755794 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,892 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.expiration_date: RSU Expiration Date: This award has no expiration date. Units will either vest or be forfeit. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 22:03 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | Exercise / conversionCommon Stock | 2,892 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-003267 · primarydocument.xml · nonDerivative · entry 1 Rivas Maria · CIK 0001755794 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,892 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 21:01 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | GiftCommon Stock | 4,528 | $0.00 | $0.00 |
DisclosureSEC source: 0001610717-24-000150 · form4.xml · nonDerivative · entry 2 Rivas Maria · CIK 0001755794 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 4,528 F1 · balance_after: Adjusted to reflect Issuer's 4-for-1 stock split effected on February 16, 2024. F2 · ownership.nature: Shares held by The Maria Rivas Trust Dated June 24, 2013, of which the Reporting Person is sole trustee. Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 21:01 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | GiftCommon Stock | 4,528 | $0.00 | $0.00 |
DisclosureSEC source: 0001610717-24-000150 · form4.xml · nonDerivative · entry 1 Rivas Maria · CIK 0001755794 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · balance_after: Adjusted to reflect Issuer's 4-for-1 stock split effected on February 16, 2024. Read SEC document |
| April 01, 2023 Filed Apr 3, 2023 22:28 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | GrantRestricted Stock Units · Derivative | 723 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-003271 · primarydocument.xml · derivative · entry 3 Rivas Maria · CIK 0001755794 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 723 Underlying: Common Stock · 723 shares Expires not disclosed F1 · derivative.exercise_price: RSU Exercise Price: There is no exercise price associated with the grant of Restricted Stock Units. F2 · derivative.expiration_date: RSU Expiration Date: This award has no expiration date. Units will either vest or be forfeit. Read SEC document |
| April 01, 2023 Filed Apr 3, 2023 22:28 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | Exercise / conversionRestricted Stock Units · Derivative | 630 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-003271 · primarydocument.xml · derivative · entry 2 Rivas Maria · CIK 0001755794 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 630 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: RSU Exercise Price: There is no exercise price associated with the grant of Restricted Stock Units. F2 · derivative.expiration_date: RSU Expiration Date: This award has no expiration date. Units will either vest or be forfeit. Read SEC document |
| April 01, 2023 Filed Apr 3, 2023 22:28 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | Exercise / conversionCommon Stock | 630 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-003271 · primarydocument.xml · nonDerivative · entry 1 Rivas Maria · CIK 0001755794 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,132 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2022 Filed Apr 4, 2022 21:51 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | GrantRestricted Stock Units · Derivative | 630 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-003131 · primarydocument.xml · derivative · entry 3 Rivas Maria · CIK 0001755794 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 630 Underlying: Common Stock · 630 shares Expires not disclosed F1 · derivative.exercise_price: RSU Exercise Price: There is no exercise price associated with the grant of Restricted Stock Units. F2 · derivative.expiration_date: RSU Expiration Date: This award has no expiration date. Units will either vest or be forfeit. Read SEC document |
| April 01, 2022 Filed Apr 4, 2022 21:51 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | Exercise / conversionRestricted Stock Units · Derivative | 502 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-003131 · primarydocument.xml · derivative · entry 2 Rivas Maria · CIK 0001755794 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 502 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: RSU Exercise Price: There is no exercise price associated with the grant of Restricted Stock Units. F2 · derivative.expiration_date: RSU Expiration Date: This award has no expiration date. Units will either vest or be forfeit. Read SEC document |
| April 01, 2022 Filed Apr 4, 2022 21:51 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | Exercise / conversionCommon Stock | 502 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-003131 · primarydocument.xml · nonDerivative · entry 1 Rivas Maria · CIK 0001755794 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 502 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 01, 2021 Filed Jul 1, 2021 22:33 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | GrantRestricted Stock Units · Derivative | 502 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-004649 · primarydocument.xml · derivative · entry 1 Rivas Maria · CIK 0001755794 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 502 Underlying: Common Stock · 502 shares Expires not disclosed F1 · derivative.exercise_price: RSU Exercise Price: There is no exercise price associated with the grant of Restricted Stock Units. F2 · derivative.expiration_date: RSU Expiration Date: This award has no expiration date. Units will either vest or be forfeit. Read SEC document |
| October 28, 2019 Filed Oct 28, 2019 16:47 UTC | Medidata Solutions, Inc. MDSO · Entity 154211 | Disposition to issuerCommon Stock | 7,081 | $92.25 | $653,222.25 |
DisclosureSEC source: 0001453814-19-000155 · wf-form4_157229557916980.xml · nonDerivative · entry 1 Rivas Maria · CIK 0001755794 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · date: On October 28, 2019, pursuant to the Agreement and Plan of Merger, dated as of June 11, 2019, by and among Dassault Systemes SE ("DS"), Dassault Systemes Americas Corp., a Delaware corporation ("Parent"), 3DS Acquisition 6 Corp., a Delaware corporation and a wholly-owned subsidiary of Parent ("Merger Sub"), and Medidata Solutions, Inc., a Delaware corporation (the "Issuer"), Merger Sub merged with and into the Issuer, with the Issuer surviving as a wholly-owned subsidiary of Parent and an indirect wholly-owned subsidiary of DS (the "Merger"). F2 · shares: Disposed of pursuant to the Merger Agreement and by virtue of the Merger, in which each share of Medidata common stock, par value $0.01 per share ("Issuer Common Stock"), issued and outstanding immediately prior to the completion of the Merger (other than restricted share awards held by continuing employees) was converted into the right to receive $92.25 in cash and without interest (the "Merger Consideration"). F2 · price: Disposed of pursuant to the Merger Agreement and by virtue of the Merger, in which each share of Medidata common stock, par value $0.01 per share ("Issuer Common Stock"), issued and outstanding immediately prior to the completion of the Merger (other than restricted share awards held by continuing employees) was converted into the right to receive $92.25 in cash and without interest (the "Merger Consideration"). Read SEC document |
| May 29, 2019 Filed May 30, 2019 16:53 UTC | Medidata Solutions, Inc. MDSO · Entity 154211 | GrantCommon Stock | 2,799 | $0.00 | $0.00 |
DisclosureSEC source: 0001453814-19-000087 · wf-form4_155924958963928.xml · nonDerivative · entry 1 Rivas Maria · CIK 0001755794 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,081 F1 · shares: Represents shares of restricted stock. The restrictions will lapse in full on May 29, 2020. F2 · price: Granted as compensation for services. Read SEC document |
| October 19, 2018 Filed Oct 23, 2018 16:39 UTC | Medidata Solutions, Inc. MDSO · Entity 154211 | GrantCommon Stock | 4,282 | $0.00 | $0.00 |
DisclosureSEC source: 0001453814-18-000135 · wf-form4_154032712817009.xml · nonDerivative · entry 1 Rivas Maria · CIK 0001755794 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,282 F1 · shares: Represents shares of restricted stock. These restrictions will lapse in full on October 19, 2019. F2 · price: Granted as compensation for services. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.